Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elaine Coustan-Smith

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
Current Opinion in Hematology|February 6, 2013
Should evaluation for minimal residual disease be routine in acute myeloid leukemia?Elaine Coustan-Smith, Dario Campana
Acta Haematologica|June 5, 2004
Minimal residual disease studies by flow cytometry in acute leukemiaDario Campana, Elaine Coustan-Smith
Best Practice & Research. Clinical Haematology|November 30, 2010
Immunologic minimal residual disease detection in acute lymphoblastic leukemia: a comparative approach to molecular testingElaine Coustan-Smith, Dario Campana
The Korean Journal of Hematology|January 16, 2013
Measurements of treatment response in childhood acute leukemiaDario Campana, Elaine Coustan-Smith
Best Practice & Research. Clinical Haematology|May 4, 2002
Advances in the immunological monitoring of childhood acute lymphoblastic leukaemiaDario Campana, Elaine Coustan-Smith
Blood|December 14, 2023
Closing the circle for ETP ALLElaine Coustan-Smith, Valentino Conter
Cytotherapy|August 8, 2016
Expanded and armed natural killer cells for cancer treatmentNoriko Shimasaki, Elaine Coustan-Smith, Takahiro Kamiya, et al.
International Journal of Laboratory Hematology|February 21, 2026
Leukaemia Flow Cytometry in YemenSaleh Abohadi, Kathy A Fuller, Elaine Coustan-Smith, et al.
Clinical Lymphoma & Myeloma|September 26, 2009
Minimal residual disease quantitation in acute myeloid leukemiaDavid Shook, Elaine Coustan-Smith, Raul C Ribeiro, et al.
Haematologica|April 10, 2002
Characterization of CD34+, CD13+, CD33- cells, a rare subset of immature human hematopoietic cellsGiuseppe Gaipa, Elaine Coustan-Smith, Elisabetta Todisco, et al.
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Current Opinion in Hematology|February 6, 2013
Should evaluation for minimal residual disease be routine in acute myeloid leukemia?Elaine Coustan-Smith, Dario Campana
Acta Haematologica|June 5, 2004
Minimal residual disease studies by flow cytometry in acute leukemiaDario Campana, Elaine Coustan-Smith
Best Practice & Research. Clinical Haematology|November 30, 2010
Immunologic minimal residual disease detection in acute lymphoblastic leukemia: a comparative approach to molecular testingElaine Coustan-Smith, Dario Campana
The Korean Journal of Hematology|January 16, 2013
Measurements of treatment response in childhood acute leukemiaDario Campana, Elaine Coustan-Smith
Best Practice & Research. Clinical Haematology|May 4, 2002
Advances in the immunological monitoring of childhood acute lymphoblastic leukaemiaDario Campana, Elaine Coustan-Smith
Blood|December 14, 2023
Closing the circle for ETP ALLElaine Coustan-Smith, Valentino Conter
Cytotherapy|August 8, 2016
Expanded and armed natural killer cells for cancer treatmentNoriko Shimasaki, Elaine Coustan-Smith, Takahiro Kamiya, et al.
International Journal of Laboratory Hematology|February 21, 2026
Leukaemia Flow Cytometry in YemenSaleh Abohadi, Kathy A Fuller, Elaine Coustan-Smith, et al.
Clinical Lymphoma & Myeloma|September 26, 2009
Minimal residual disease quantitation in acute myeloid leukemiaDavid Shook, Elaine Coustan-Smith, Raul C Ribeiro, et al.
Haematologica|April 10, 2002
Characterization of CD34+, CD13+, CD33- cells, a rare subset of immature human hematopoietic cellsGiuseppe Gaipa, Elaine Coustan-Smith, Elisabetta Todisco, et al.
Pageof 7